Home
Silver Point Capital, 10% Owner: Keenova Therapeutics Buy · Filed 25/12/10
Trade details
- Type
- Insider buy
- Amount
- $11,623,942.5
- Shares · price
- 130,974 sh · $88.75 a share
- Held after
- 4,702,714 sh
- Stock
- Keenova Therapeutics
- Trade date
- 25/12/08
- Filed
- 25/12/10
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +2.9%
Keenova Therapeutics trades, last 26 weeks
Silver Point Capital's recent trades
- Silver Point Capital
Planned saleQVC Group
Planned saleQVC Group
QVCG
$11.8M
720,000 sh
$11.8M
Filed 09/03
Traded 09/03
- Silver Point Capital
Planned saleQVC Group
Planned saleQVC Group
QVCG
$875K
50,000 sh
$875K
Filed 08/11
Traded 08/11
- Silver Point Capital
BuyKeenova Therapeutics
BuyKeenova Therapeutics
$19M
210,000 sh
$19M
Filed 05/21
Traded 05/20
- Silver Point Capital
BuyKeenova Therapeutics
BuyKeenova Therapeutics
$17M
187,500 sh
$17M
Filed 05/21
Traded 05/19
- Silver Point Capital
BuyKeenova Therapeutics
BuyKeenova Therapeutics
$37.1M
410,000 sh
$37.1M
Filed 04/17
Traded 04/17